Weekly Digest – June 2025 Weekly Digest – June 2025 03 June 2025: European Commission approves ADCETRIS (Brentuximab vedotin) for the treatment of adult patients with newly diagnosed stage IIb/III/IV hodgkin lymphoma in combination with ECADD Takeda’s ADCETRIS-based regimen BrECADD […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id